A175250 logo

Icure Pharmaceutical Incorporation Stock Price

KOSDAQ:A175250 Community·₩81.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A175250 Share Price Performance

₩2,170.00
653.00 (43.05%)
₩2,170.00
653.00 (43.05%)
Price ₩2,170.00

A175250 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
1 Reward

Icure Pharmaceutical Incorporation Key Details

₩83.8b

Revenue

₩75.8b

Cost of Revenue

₩8.0b

Gross Profit

₩13.6b

Other Expenses

-₩5.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-150.35
9.55%
-6.70%
75.2%
View Full Analysis

About A175250

Founded
2000
Employees
210
CEO
n/a
WebsiteView website
www.icure.co.kr

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfumes, body mists, and hair and body fragrances. Icure Pharmaceutical Incorporation was founded in 2000 and is based in Seoul, South Korea.

Recent A175250 News & Updates

Recent updates

No updates